We read with great interest the article of Ratziu and colleagues, who evaluated the potential of thrombospondin-2 (TSP2), insulin-like growth factor binding protein 7, CD163 and growth differentiation ...

New review shows statins remain first-line therapy in MASLD, while PCSK9 inhibitors offer potential but require more evidence. Learn more about evolving treatment guidance.

At the Liver Meeting sponsored by the American Association for the Study of Liver Diseases, investigators presented new insights into how the immune makeup of fibrotic tissue may influence ...

A striking rise in deaths from alcohol-related liver disease (ALD) is disproportionately impacting people without a college ...

A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a ...

whether human stem cells (i.e. special types of cells that can renew themselves and develop into many different cell types in the body) are beneficial in reducing death in people with decompensated ...